A droplet digital polymerase chain reaction (ddPCR) test was recently developed and validated by ICON to evaluate the ratio of unmethylated to total target sequence (U/U+M) in ccfDNA isolated from K2EDTA whole blood (WB/K2EDTA) plasma. Read more about how this validated ddPCR test is used to monitor the death of target gene expressing CDP in patient samples. https://ow.ly/XCrF50T8mPu
About us
ICON Strategic Solutions is the global leading provider of Functional Service Provision (FSP) services. Through combined functional, operational, and talent expertise, ICON offers FSP models that provide cost-savings, clinical expertise and significantly improve business performance. Follow us for the latest industry insights as well as vacancies and insight into life at ICON.
- Website
-
https://www.iconplc.com/services/strategic-solutions/
External link for ICON Strategic Solutions
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Dublin
- Type
- Public Company
Locations
-
Primary
South County Business Park
Dublin , GB
Employees at ICON Strategic Solutions
Updates
-
ICON’s Patient Centred Outcomes (PCO) team supports Sickle Cell Awareness Month. With over 4550 staff located across Europe and North America, the PCO team are constantly working to advance knowledge and research across numerous therapeutic areas, including understanding the impact of genetic conditions on patients’ quality of life. The PCO team have conducted a wide range of research into genetic conditions such as sickle cell disease. Here are some of PCO’s key publications which shine a spotlight on the valuable insights the patient and caregiver voices bring to sickle cell research. • Patient and Caregiver Perspectives on Care-Seeking During a Vaso-Occlusive Crisis in Sickle Cell Disease: Results from Qualitative Interviews in Canada: https://ow.ly/gjcF50TlRlL • Patient-Reported Experiences in Voxelotor-Treated Children and Adults with Sickle Cell Disease: A Semistructured Interview Study: https://ow.ly/qleO50TlRlI #SickleCellAwarenessMonth #ICONplc #ClinicalOutcomeAssessment #PatientCentredOutcomes #QualiftyofLife
-
The theme for this year’s World Patient Safety Day centers on enhancing diagnostic accuracy to improve patient safety. At ICON, we recognize the critical importance of timely and accurate diagnoses in safeguarding patient outcomes. We remain dedicated to advancing research and development in diagnostic tools and technologies, further strengthening our commitment to patient safety. Learn more about our Device and Diagnostic division here: https://ow.ly/eO1m50TphwC
-
On September 15th, we marked World Lymphoma Awareness Day, which is part of the broader Blood Cancer Awareness Month. Despite being the 5th most common cancer, lymphoma remains unfamiliar to many, with significant gaps in public knowledge about its symptoms. This year’s theme, “Let’s Talk Lymphoma”, emphasizes the importance of ensuring no one faces lymphoma alone. We encourage open conversations—whether it’s sharing symptoms or discussing personal journeys with the disease. At ICON, we are proud to support Blood Cancer Awareness Month. Explore career opportunities with our Oncology teams here: https://ow.ly/np5H50TpeyO
-
Listen to our latest Bioanalysis Zone podcast where we discuss immunogenicity considerations for therapeutic proteins and the current analytical methodologies for detecting and characterizing anti-drug antibodies (ADAs), industry best practices for achieving high-quality ADA assays, and the advantages and limitations of singlicate ADA analysis compared with alternative techniques. We also discuss the emerging trends in the field of immunogenicity and how they may shape the future of therapeutic protein development. https://ow.ly/8HY950SFNjZ #immunogenicity
-
ICON has been recognised as one of the "World's Best Companies 2024" by TIME Magazine and Statista, and is the highest ranked clinical research organisation on the list. This achievement reflects the dedication and expertise of our global team and their commitment to innovation and excellence. Our focus on advancing healthcare and delivering value to our customers remains at the core of everything we do. Interested in being part of a globally recognised leader in clinical research? Visit our careers site today: https://ow.ly/Q27a50Tm5pt
-
Leverage the industry's most experienced reader network of cardiovascular (CV) physicians and experts who will help you navigate the latest changes in cardiac safety trial requirements. Find out how we can help you: https://ow.ly/IwBQ50T8zez
-
On August 1st, ICON Mexico hosted a Blood Donation Campaign in collaboration with Cruz Roja Mexicana I.A.P. and our ICON4U Social Responsibility Chapter. This initiative represents a significant advancement in promoting voluntary blood donation as a valuable resource for those in need. If you would like to review opportunities to join ICON in Latin America please follow the link: https://ow.ly/WNgO50Tlbtp
-
ICON Strategic Solutions reposted this
Today, the Swansea ICON office hosted a wonderful Garden Party, bringing the team together for a day of relaxation and connection. Colleagues enjoyed a variety of refreshments from the food truck and took part in some fun sports activities, fostering teamwork and a sense of community. Thank you to everyone who contributed to making the event a success!
-
+3
-
Last Friday, ICON Argentina hosted a memorable Family Day filled with fun and learning. CIRCO RECICLADO SAS led an engaging performance that highlighted the principles of Reduce, Reuse, and Recycle, bringing sustainability to life with humor and creativity. Children enjoyed workshops where they made crafts from recycled materials and received a special gift to share with their families. It was a fantastic day that combined entertainment with important lessons on caring for our environment. Take a look at our careers page for opportunities in Argentina: https://ow.ly/B5Ms50Tk6Gk
-
+1